Deep Dive: FDA to revoke Red No. 3 authorization
January 15th 2025, the FDA announced that they would be revoking their authorizations for Red No. 3 in food and ingested drugs. The Lycored team comments on the situation.
During Sundance, our team lead Jillian Romero spoke at the Compelling Accounts of Intensive Care panel, which brought together individuals who have witnessed first hand the incredible transformative power of compassion. It was so uplifting and reassuring to be surrounded by such an empathetic and passionate community, and we felt honored to hear the stories of others while sharing our own. After the panel discussion, our team was invited to tour Primary Children’s Hospital in Salt Lake City, which was the first site of Sophie’s Place—a charity that uses music therapy to treat young people suffering from pain, chronic illness, and serious injury. The tour was led by Sophie’s parents Ann-Marie and Kent Barton.
January 15th 2025, the FDA announced that they would be revoking their authorizations for Red No. 3 in food and ingested drugs. The Lycored team comments on the situation.
In our latest webinar, Elizabeth Tarshish, PhD, Head of Scientific Value & Strategy at Lycored discusses Lycomato’s impact on cellular and mitochondrial health and how it promotes longevity through a...
Reflecting on my fourth year at Lycored, I'm filled with gratitude for our incredible journey together in 2024.
Interested in speaking directly with a member of our team?
Click below to get in touch.